These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17848497)

  • 21. Endovascular dialysis interventions in the era of DOQI.
    Greenberg JI; Suliman A; Angle N
    Ann Vasc Surg; 2008 Sep; 22(5):657-62. PubMed ID: 18619775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of route of EPO administration on hemodialysis arteriovenous vascular access failure: a randomized controlled trial.
    Lee YK; Koo JR; Kim JK; Park II; Joo MH; Yoon JW; Noh JW; Vaziri ND
    Am J Kidney Dis; 2009 May; 53(5):815-22. PubMed ID: 19324483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodialysis access graft failure: time to revisit an unmet clinical need?
    Rotmans JI; Pasterkamp G; Verhagen HJ; Pattynama PM; Blankestijn PJ; Stroes ES
    J Nephrol; 2005; 18(1):9-20. PubMed ID: 15772918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium channel antagonists reduce restenosis after percutaneous transluminal angioplasty of an arteriovenous fistula in hemodialysis patients.
    Doi S; Masaki T; Shigemoto K; Harada S; Yorioka N
    Ther Apher Dial; 2008 Jun; 12(3):232-6. PubMed ID: 18503701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The native arteriovenous fistula in 2007. Research needs.
    Besarab A; Ravani P; Spergel LM; Roy-Chaudhury P; Asif A
    J Nephrol; 2007; 20(6):668-73. PubMed ID: 18046668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Notes on angiotensin inhibition and vascular access survival: time for randomized controlled trials.
    Diskin CJ
    Nephrol Dial Transplant; 2006 Mar; 21(3):823; author reply 824. PubMed ID: 16401624
    [No Abstract]   [Full Text] [Related]  

  • 28. Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.
    Viecelli AK; Pascoe EM; Polkinghorne KR; Hawley CM; Paul-Brent PA; Badve SV; Cass A; Johnson DW; Kerr PG; Mori TA; Scaria A; Hooi SL; Ong ML; Irish AB;
    Nephrology (Carlton); 2016 Mar; 21(3):217-28. PubMed ID: 26205903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CARI guidelines. Pharmacological approaches to preventing vascular access failure.
    Polkinghorne K;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S12-6. PubMed ID: 18713119
    [No Abstract]   [Full Text] [Related]  

  • 30. Predictors of early dialysis vascular-access failure after thrombolysis.
    Crikis S; Lee D; Brooks M; Power DA; Ierino FL; Levidiotis V
    Am J Nephrol; 2008; 28(2):181-9. PubMed ID: 17960056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular brachytherapy for hemodialysis vascular access dysfunction: exploring an unmet clinical need.
    Roy-Chaudhury P; Duncan H; Barrett W; Elson H; Narayana A; Foley J; Misra S; Lynch PM; Zuckerman D
    J Invasive Cardiol; 2003 Jan; 15 Suppl A():25A-30A. PubMed ID: 12668839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adding access blood flow surveillance to clinical monitoring reduces thrombosis rates and costs, and improves fistula patency in the short term: a controlled cohort study.
    Tessitore N; Bedogna V; Poli A; Mantovani W; Lipari G; Baggio E; Mansueto G; Lupo A
    Nephrol Dial Transplant; 2008 Nov; 23(11):3578-84. PubMed ID: 18511608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes of transposed basilic vein arteriovenous fistulae.
    Moossavi S; Tuttle AB; Vachharajani TJ; Plonk G; Bettmann MA; Majekodunmi O; Russell GB; Regan JD; Freedman BI
    Hemodial Int; 2008 Jan; 12(1):80-4. PubMed ID: 18271846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.
    Viecelli AK; Polkinghorne KR; Pascoe EM; Paul-Brent PA; Hawley CM; Badve SV; Cass A; Hooi LS; Kerr PG; Mori TA; Ong LM; Voss D; Johnson DW; Irish AB;
    PLoS One; 2019; 14(3):e0213274. PubMed ID: 30913208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency.
    Ishii Y; Sakamoto S; Kronengold RT; Virmani R; Rivera EA; Goldman SM; Prechtel EJ; Hill JG; Damiano RJ
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1237-45; discussion 1245-6. PubMed ID: 18544361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
    Bowden RG; Jitomir J; Wilson RL; Gentile M
    J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in hemodialysis vascular access from the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) 2000 to 2005.
    Moist LM; Chang SH; Polkinghorne KR; McDonald SP;
    Am J Kidney Dis; 2007 Oct; 50(4):612-21. PubMed ID: 17900461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.